Harmony Biosciences
HRMY
HRMY
181 hedge funds and large institutions have $2.21B invested in Harmony Biosciences in 2022 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 76 increasing their positions, 42 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
16% more capital invested
Capital invested by funds: $1.9B → $2.21B (+$310M)
2.16% more ownership
Funds ownership: 76.21% → 78.38% (+2.2%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $224K
Holders
181
Holding in Top 10
10
Calls
–
Puts
$224K
Top Buyers
| 1 | +$33.5M | |
| 2 | +$14.6M | |
| 3 | +$14.5M | |
| 4 |
Two Sigma Investments
New York
|
+$10.5M |
| 5 |
Two Sigma Advisers
New York
|
+$8.12M |
Top Sellers
| 1 | -$58.2M | |
| 2 | -$30.1M | |
| 3 | -$15.3M | |
| 4 |
NP
Newlight Partners
New York
|
-$12.1M |
| 5 |
PA
Perceptive Advisors
New York
|
-$10.2M |